Seattle Genetics is making its mark on the medical industry in two very different ways. They have chosen to be sure that they can offer cancer drugs to everyone who needs them, and they are based on the research that was done by Clay Siegall with antibodies. He created a company that is helping cure as many patients as it can, but he is also offering his assistance to other companies that want to be able to help patients.
Siegall has been named to the board of directors at Mirna Therapeutics, and he is trying to help them be just as successful as his company is. He believes that there is a lot of cooperation that can go on to help a lot of different patients, and he also believes that he can do things for the industry that will change the way people are cured. It is makes sure that all the companies in the industry are using their best information to make changes to the world.
Seattle Genetics is a large company that has two main drugs, but they also want to release nearly a doze more over the next few years. They can help other companies get much better at what they do, and they want to make sure that they can give doctors the confidence that they need to be great at what they do.
Clay Siegall wants to offer people a chance to learn a lot about their own care through his company, and he also believes that other companies can use his expertise. he has built a company that has its own stock symbol, and he also knows that people will be able to make changes to the way they are getting treatment. Siegall‘s work in the medical industry is helping treat cancer and expand treatment at the same time.